Tag - cancer

 
 

CANCER

WORLD / Science & Health
Nov 3, 2017
Good gut microbes may help immunotherapy drugs shrink tumors
Cancer patients with high levels of good gut bacteria appear more likely to respond to immunotherapy, potentially opening up a new way to optimize the use of modern medicines that are highly effective but only work in some people.
Japan Times
JAPAN / Science & Health
Oct 26, 2017
Venture behind worm cancer-screening method raises ¥30 million from Shinkin Capital
Hirotsu Bio Science, a medical venture developing a cancer screening tool using nematodes, has secured ¥30 million in funding from Shinkin Capital Co. to accelerate growth in overseas markets, the firm announced Thursday.
Japan Times
COMMUNITY / How-tos / LIFELINES
Oct 25, 2017
PanCAN Japan makes strides against pancreatic cancer
PanCAn Japan supports research projects and advocates for new medical techniques to improve both treatment for pancreatic cancer patients and early detection of the disease.
Japan Times
JAPAN / Science & Health / A MATTER OF HEALTH
Oct 25, 2017
Cancer and breast density: What are doctors withholding?
October is Pink Ribbon Month: an annual campaign to increase awareness about breast cancer and get more women screened in order to catch the disease in its early stages, which will boost survival rates.
Japan Times
JAPAN / Crime & Legal
Oct 25, 2017
Yokohama District Court finds government and two firms liable in asbestos case
The government and two manufacturers of construction materials were found liable for ¥306 million in damages over asbestos-related health problems, according to a ruling by the Yokohama District Court on Tuesday.
Japan Times
COMMUNITY / How-tos / LIFELINES
Oct 11, 2017
For those living with cancer, a place to talk in Tokyo that's neither home nor hospital
Maggie's Tokyo opened its doors in October last year, offering a space for cancer patients and their family members and friends to talk.
Japan Times
Reference / GENERATIONAL CHANGE
Oct 8, 2017
Biologist harnesses power of tiny worms in project that could reshape way cancer is screened and treated
Call it worm power.
Japan Times
LIFE / Lifestyle
Sep 30, 2017
Winning the battle against breast cancer
Oct. 1 marks the start of the annual Pink Ribbon campaign to raise awareness about breast cancer.
BUSINESS
Sep 11, 2017
Novartis posts win, Roche a flop in drug trials targeting skin cancer
Swiss drugmaker Novartis notched a trial win for its drug cocktail against skin cancer on Monday, while a rival treatment from Roche with slipping sales failed in a separate study with a similar patient group.
Japan Times
WORLD / Science & Health
Sep 8, 2017
Alcohol industry distorts cancer risk, study say
The alcohol industry uses denial, distortion and distraction to mislead people about the risks of developing cancer from drinking, often employing similar tactics to those of the tobacco industry, a study said on Thursday.
Japan Times
BUSINESS
Aug 22, 2017
California jury orders Johnson & Johnson to pay $417 million to ovarian cancer victim
Johnson & Johnson on Monday was ordered by a California jury to pay $417 million to a woman who claimed she developed ovarian cancer after using the company's talc-based products for feminine hygiene.
JAPAN / FUKUSHIMA FILE
Aug 20, 2017
Fukushima Medical and Ohio State team up on radiotherapy
Fukushima Medical University has launched an international exchange program with Ohio State University that will focus on developing experts in cancer radiation therapy.
Japan Times
JAPAN / Science & Health
Aug 17, 2017
Japan's working cancer patients face pay cuts, mounting bills and lack of awareness, study shows
Medical advances are enabling more cancer patients to return to work after treatment, but not without difficulties. Many face pay cuts and struggle to cover medical bills or living costs, according to a recent survey of working cancer patients by Lifenet Insurance Co.
Japan Times
JAPAN / Science & Health
Aug 9, 2017
Japan's five-year cancer survival rate at 65.2%, survey of 209 hospitals shows
The survey covered 214,500 people diagnosed with cancer in 2008 at 209 hospitals designated for cancer treatment as of 2015.
Japan Times
JAPAN / Science & Health
Aug 8, 2017
AstraZeneca seeks Japan's first approval for hereditary cancer drug in relapsed sufferers
Olaparib, already approved in the United States and the European Union, acts against cancers in people with hereditary mutations in genes associated with breast and ovarian cancer.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?